Viewing data from:

ISOSORBIDE MONONITRATE

ANDA

ISOSORBIDE MONONITRATE | A075522 | DEXCEL LTD

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 6 NDCs

Highest NADAC/Unit

$0.0952

per ea

Lowest NADAC/Unit

$0.0751

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
62135058790ISOSORBIDE MONONIT ER 60 MG TB	$0.0952	EA	Generic	—	2026-06-17
42799095901ISOSORBIDE MONONIT ER 60 MG TB	$0.0952	EA	Generic	—	2026-06-17
42799095902ISOSORBIDE MONONIT ER 60 MG TB	$0.0952	EA	Generic	—	2026-06-17
62135058690ISOSORBIDE MONONIT ER 30 MG TB	$0.0751	EA	Generic	—	2026-06-17
42799095801ISOSORBIDE MONONIT ER 30 MG TB	$0.0751	EA	Generic	—	2026-06-17
42799095802ISOSORBIDE MONONIT ER 30 MG TB	$0.0751	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs (4 FSS)

Lowest Price

$5.49

Highest Price

$34.47

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
42799-0958-01ISOSORBIDE MONONITRATE 30MG TAB,SA	$5.49	FSS	AvKare, LLC	06/14/2028
42799-0958-02ISOSORBIDE MONONITRATE 30MG TAB,SA	$25.81	FSS	AvKare, LLC	06/14/2028
42799-0959-01ISOSORBIDE MONONITRATE 60MG TAB,SA	$7.23	FSS	AvKare, LLC	06/14/2028
42799-0959-02ISOSORBIDE MONONITRATE 60MG TAB,SA	$34.47	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain0 active DMFs1 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

SHANDONG NEW TIME PHARMACEUTICAL CO LTDInactiveISOSORBIDE MONONITRATE (NON-STERILE, BULK FORM)

DMF 208162007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 17, 2000	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 60MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Apr 17, 2000

No patent or exclusivity listings for this strength.

#002 — 30MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Sep 20, 2016